Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Silpa NarayananDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USAChao‐Yun CaiDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USAYehuda G. AssarafThe Fred Wyszkowski Cancer Research Laboratory, Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, IsraelHuiqin GuoDepartment of Thoracic Surgery, Beijing Sijitan Hospital, Capital Medical University, Beijing, ChinaQingbin CuiDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA; School of Public Health, Guangzhou Medical University, Guangzhou, 511436, ChinaLiuya WeiDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA; School of Pharmacy, Weifang Medical University, Weifang, 261053, ChinaJuanjuan HuangDepartment of Physics, Technical University of Munich, 85748, Garching, GermanyCharles R. AshbyDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. Electronic address: [email protected]Zhe‐Sheng ChenDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. Electronic address: [email protected]
2019en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba